Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021 [0.03%]
2013至2021年多发性硬化症疾病修正疗法的列表价格和净价格的变化
Daniel M Hartung,Nico Gabriel,Walid F Gellad et al.
Daniel M Hartung et al.
Objectives: The objective of this study was to evaluate changes in net and list prices of branded multiple sclerosis (MS) disease-modifying therapies (DMTs) between 2013 and 2021. ...
Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular Disorders [0.03%]
神经肌肉疾病成人患者生命质量与功能状态关系的大样本评估研究
Karen S W Wong,Anando Sen,Jassi Michell-Sodhi et al.
Karen S W Wong et al.
Background and objectives: Health-related quality of life (HR-QoL) is compromised in patients with neuromuscular disorders (NMDs). Disease severity alone does not predict HR-QoL; there are other known predictors including...
Trends in Industry-Sponsored Research Payments and General Payments to Neurologists: Open Payments Program 2015-2023 [0.03%]
2015至2023年神经学领域行业资助研究支付和一般支付的变化趋势：开放支付项目
Tyler S Garman,Zeyad Hammadeh,Misop Han et al.
Tyler S Garman et al.
Objectives: The aim of this study was to characterize trends in industry-sponsored research payments (ISRPs) and general payments to neurologists. Methods...
Erratum: Albendazole-Praziquantel Dual Therapy Compared With Albendazole Monotherapy in Neurocysticercosis: A Systematic Review and Meta-Analysis of RCTs [0.03%]
albendazole- praziquantal双联疗法与单用albendazole治疗囊尾蚴病：系统评价和meta分析的更正性论文
Jorge Resende Gondim Jasmineiro Pitanga,Murilo Marmori Cruccioli,Pedro Henrique Teixeira Carneiro et al.
Jorge Resende Gondim Jasmineiro Pitanga et al.
[This corrects the article DOI: 10.1212/CPJ.0000000000200567.]. © 2026 American Academy of Neurology.
Published Erratum
Neurology. Clinical practice. 2026 Apr;16(2):e200609. DOI:10.1212/CPJ.0000000000200609 2026
Practical Management of Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome [0.03%]
进行性多灶性白质脑病和免疫重建炎症综合征的管理
Guillaume Martin-Blondel,Busranur Agac,Irene Cortese
Guillaume Martin-Blondel
Purpose of review: The aim of this narrative review was to provide treating physicians with practical guidance on the management of progressive multifocal leukoencephalopathy (PML), offering a rational, evidence-informed ...
Martina Gnazzo,Giulia Pisanò,Valentina Baldini et al.
Martina Gnazzo et al.
Objectives: Narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) are rare, chronic neurologic disorders of hypersomnolence. Narcolepsy type 1 results from the selective loss of orexin-producing neurons, leading to markedly...
Neuropsychiatric Features in Patients With Idiopathic Normal Pressure Hydrocephalus: A Systematic Review and Meta-Analysis [0.03%]
特发性正常压力脑积水患者的神经精神特征系统回顾和元分析
Clara Belessiotis-Richards,Emma Brady,Esha Abrol et al.
Clara Belessiotis-Richards et al.
Purpose of review: Idiopathic normal pressure hydrocephalus (iNPH) is a treatable condition characterized by impaired gait, cognition, and bladder function. Neuropsychiatric symptoms may be important in iNPH but are poorl...
Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER Study [0.03%]
亚洲、中东和拉丁美洲发作性偏头痛患者依鲁瓦单抗对患者报告结果的影响：EMPOwER研究的结果
Shuu-Jiun Wang,Artemio A Roxas,Bibiana Saravia et al.
Shuu-Jiun Wang et al.
Background and objectives: Migraine is a significant disabling neurologic headache disorder globally. Evaluating patient-related outcomes (PROs) is necessary to assess the impact of therapeutic interventions in preventive...
The SIH Impact Inventory: A Pilot Study of a Novel Instrument Assessing Quality of Life in Spontaneous Intracranial Hypotension [0.03%]
自发性颅内低压新型生活质量评估量表(SIHHII)的初步研究
Victor Liaw,Deborah I Friedman
Victor Liaw
Background and objectives: Spontaneous intracranial hypotension (SIH) profoundly affects quality of life. We aimed to identify and quantify various aspects of patients' experiences with SIH. ...
Defining Relapse and Disease Activity in Neurosarcoidosis: A Systematic Review and Proposed Framework [0.03%]
神经囊性组织炎复发和疾病活动的定义：系统评价及建议框架
Greer Waldrop,Susana C Dominguez Penuela,Paula Barreras et al.
Greer Waldrop et al.
Purpose of review: There is no consensus or standardized framework to characterize disease activity in CNS neurosarcoidosis, and the existing literature is highly heterogeneous. Here, we aimed to aggregate all longitudina...